3rd Quarter - Report

MEDIMMUNE, LLC. for MEDIMMUNE LLC

Period 3rd Quarter 2008 Filed Oct 20, 2008 Signed by Brian Rosen, Senior Director Government Affairs

Official filing
Firm
MEDIMMUNE, LLC.
Client
MEDIMMUNE LLC
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 5629 Pathway for Biosimilars Act : All Provisions H.R. 3610 Food and Drug Import Safety Act: All drug related provisions H.R. 5839 The Safeguarding America's Pharmaceutical Act: All provisions SCHIP Reauthorization - All provisions Issues Impacting Vaccines Issues impacting school-based influenza projects Issues impacting new-born access to care

Foreign entity interest: As the ultimate parent of MedImmune, LLC., Astra Zeneca PLC, has interests in the issues lobbied.

LobbyistCovered position, as disclosed
VANESSA PROCTER —
BRIAN M ROSEN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 5839 (110th), H.R. 3610 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.